Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CYAN
Upturn stock ratingUpturn stock rating

Cyanotech Corporation (CYAN)

Upturn stock ratingUpturn stock rating
$0.33
Last Close (24-hour delay)
Profit since last BUY-21.43%
upturn advisory
WEAK BUY
BUY since 15 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: CYAN (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.33
high$

Analysis of Past Performance

Type Stock
Historic Profit -26.81%
Avg. Invested days 23
Today’s Advisory WEAK BUY
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 2.53M USD
Price to earnings Ratio -
1Y Target Price 14
Price to earnings Ratio -
1Y Target Price 14
Volume (30-day avg) -
Beta -0.24
52 Weeks Range 0.23 - 0.89
Updated Date 06/29/2025
52 Weeks Range 0.23 - 0.89
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.45

Earnings Date

Report Date 2025-06-20
When -
Estimate -
Actual -0.09

Profitability

Profit Margin -13.23%
Operating Margin (TTM) -7.18%

Management Effectiveness

Return on Assets (TTM) -6.16%
Return on Equity (TTM) -30.95%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 14199886
Price to Sales(TTM) 0.1
Enterprise Value 14199886
Price to Sales(TTM) 0.1
Enterprise Value to Revenue 0.59
Enterprise Value to EBITDA 21.94
Shares Outstanding 7232220
Shares Floating 4836617
Shares Outstanding 7232220
Shares Floating 4836617
Percent Insiders 38.34
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Cyanotech Corporation

stock logo

Company Overview

overview logo History and Background

Cyanotech Corporation, founded in 1983 in Kailua-Kona, Hawaii, focuses on cultivating microalgae for nutritional and health products. It has grown from a research firm to a producer of high-value natural products.

business area logo Core Business Areas

  • Nutritional Products: Production and sale of dietary supplements derived from microalgae, including spirulina and astaxanthin.
  • Animal Nutrition: Provision of microalgae-based ingredients for animal feeds, promoting animal health and well-being.
  • Contract Manufacturing: Manufacturing nutritional products for other companies

leadership logo Leadership and Structure

Gerald R. Cysewski is the Chairman, President and CEO. The company has a standard corporate structure with departments for research, production, sales, and marketing.

Top Products and Market Share

overview logo Key Offerings

  • BioAstin Hawaiian Astaxanthin: A natural antioxidant supplement. The global astaxanthin market is competitive, with companies like Fuji Chemical Industry and BASF. Market share data for BioAstin is not publicly disclosed but it is a top competitor. Revenue data is also not publicly disclosed. Competitors include Fuji Chemical Industry and BASF
  • Nutrex Hawaii Spirulina Pacifica: A blue-green algae supplement known for its nutritional content. The global spirulina market is fragmented. Market share data for Spirulina Pacifica is not publicly disclosed but it is one of the top competitors in the industry. Revenue data is also not publicly disclosed. Competitors include DIC Corporation and Earthrise Nutritionals.

Market Dynamics

industry overview logo Industry Overview

The nutraceuticals industry is growing, driven by increasing consumer awareness of health and wellness, with strong demand for natural and plant-based products.

Positioning

Cyanotech is positioned as a premium supplier of high-quality microalgae-based products, emphasizing its Hawaiian origin and sustainable farming practices.

Total Addressable Market (TAM)

The global nutraceuticals market is estimated at hundreds of billions of dollars, and the astaxanthin and spirulina markets are multi-billion dollar segments. Cyanotech captures a small but significant share of these markets.

Upturn SWOT Analysis

Strengths

  • Unique Hawaiian location and brand image
  • Sustainable farming practices
  • High-quality products
  • Established brand recognition

Weaknesses

  • Relatively small scale compared to larger competitors
  • Vulnerability to weather-related disruptions
  • Dependence on specific microalgae species

Opportunities

  • Expanding into new markets and product categories
  • Increasing consumer demand for natural and sustainable products
  • Developing new applications for microalgae
  • Strategic partnerships and acquisitions

Threats

  • Competition from larger companies
  • Price fluctuations in raw materials
  • Changes in regulations
  • Potential for contamination or quality issues

Competitors and Market Share

competitor logo Key Competitors

  • DIC Corp (6324.T)
  • Fuji Chemical Industry (4996.T)
  • BASF (BAS.DE)

Competitive Landscape

Cyanotech benefits from its unique location and brand image, but faces competition from larger, more diversified companies with greater resources.

Growth Trajectory and Initiatives

Historical Growth: Cyanotech has experienced steady revenue growth over the past several years, driven by increased demand for its core products.

Future Projections: Without access to analyst estimates, I can not provide projections.

Recent Initiatives: Cyanotech continues to invest in research and development to expand its product portfolio. Further, the company invests in sustainability efforts.

Summary

Cyanotech Corporation is a niche player in the nutraceuticals market, specializing in microalgae-based products. The company benefits from its Hawaiian location and sustainable farming practices, but faces competition from larger companies. Steady growth in revenue and net income indicate solid performance. To maintain its trajectory, Cyanotech needs to carefully navigate price fluctuations and regulatory changes, while continuing to innovate and seek strategic opportunities.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Cyanotech Corporation's website
  • Industry reports on nutraceuticals and microalgae
  • Financial news sources

Disclaimers:

This analysis is based on publicly available information and does not constitute financial advice. The information is believed to be accurate, but no guarantees are made regarding its completeness or accuracy. Market share data is estimates. Financial data is placeholder and should be replaced with actual values.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Cyanotech Corporation

Exchange NASDAQ
Headquaters Kailua-Kona, HI, United States
IPO Launch date 1993-06-22
President, CEO & Director Mr. Matthew Keith Custer
Sector Consumer Defensive
Industry Packaged Foods
Full time employees 83
Full time employees 83

Cyanotech Corporation, an agricultural company, engages in the production of natural products derived from microalgae worldwide. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.